2019/12/06 News
AMED and PeptiStar announced they accomplished the CiCLE project goal, “establishment of a global leading contract manufacturing organization (CMO) for constrained peptide medicines".
AMED CiCLE事業の目標である「特殊ペプチド原薬の安定的な供給体制の基盤構築」を達成しました。
AMED: Japan Agency for Medical Research and Development
CiCLE: Cyclic innovation for Clinical Empowerment
詳しくは下記のPDFをご覧ください。
(the announcememt was made in Japanese only)
特殊ペプチド原薬の安定的な供給体制の基盤構築を達成